Stitch Fix (SFIX) Posts Q2 Loss of $0.02/Share, Revenue Rises 9%
Stitch Fix reports Q2 fiscal 2026 loss of $0.02 per share on revenue of $337.5M, up 3.8% year-over-year, with adjusted…
ADVERTISEMENT
Earnings
Flotek (FTK) Earnings Plunge 55% Despite 33% Revenue Jump to $67.5M on Margin Pressure
Flotek posts $0.08 EPS on 33% revenue growth to $67.5M, but earnings fall 55% year-over-year as margins compress despite strong…
Stitch Fix (SFIX) Q2 Earnings: $0.02 Loss Meets Estimates as Revenue Stabilizes at $341.3M
Stitch Fix posts Q2 loss of $0.02 per share, matching estimates, as revenue of $337.5M holds flat while year-over-year comparisons…
Verrica (VRCA) Q4 Loss Narrows Sharply to $0.51/Share as Revenue Surges to $5.1M
Verrica narrows Q4 loss 72% year-over-year to -$0.51 per share as revenue surges 1,383% to $5.1M, though sequential revenue drops…
Navitas Semiconductor (NVTS) Q4 Loss Narrows to $0.05/Share, Shares Surge 23%
Navitas Semiconductor posts narrower-than-expected Q4 loss of $0.05/share; shares surge 23% despite ongoing cash burn and revenue pressure.
Nio (NIO) Surges 15% After Posting First-Ever Quarterly Profit, Beating EPS Estimates
Nio posts first-ever quarterly profit with Q4 EPS of $0.29 vs $0.05 estimate; shares surge 15% on delivery growth and…
Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS
Figure Technology Solutions missed Q4 EPS estimates by 36% yet shares surged 21% on sequential revenue growth and undisclosed forward…
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position.
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA…
Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates
Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line…